Preventing kidney damage from heart attack treatment
This trial tests whether drinking extra water during treatment for a heart attack can help prevent kidney damage caused by the heart procedure. If you are eligible, this could be a simple way to protect your kidneys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a major heart attack (STEMI) and are scheduled for a procedure to open the blocked artery.
- You have normal to moderately reduced kidney function.
- You are able to drink fluids by mouth safely.
- You have not had an allergic reaction to the contrast dye used during the procedure.
- You do not have fluid in the lungs or need a breathing tube.
- You are not on dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at ways to improve kidney outcomes after a coronary angiogram and/or stent procedure. If you’re having one of these heart procedures and your kidneys aren’t already severely affected, the study may help reduce the risk of kidney worsening around the time of the procedure.
This trial tests whether a simple “arm conditioning” technique done remotely before a procedure can help prevent kidney injury caused by contrast dye used during certain heart catheter tests. You might benefit if you’re having a coronary angiogram and your kidney function is reduced, but you’re not on dialysis.
This trial tests if drinking beetroot juice can help protect your kidneys from damage caused by the dye used during heart procedures. It is for people hospitalized with a certain type of heart attack who are at moderate to high risk of kidney problems.
This trial tests whether using a much smaller amount of contrast dye for an invasive heart scan is safer for people with acute kidney injury (AKI). It may help reduce further kidney stress while still allowing doctors to look at coronary (heart) arteries.
This trial tests whether a simple inorganic nitrate pill can protect your kidneys from damage caused by contrast dye used in heart catheterization or CT scans. It is for people whose kidneys are already somewhat weak, making them at higher risk for this type of injury.
This trial studies whether a device called Dye-Vert Plus can lower the risk of kidney injury from contrast dye during heart catheter procedures (CAG and/or PCI). It focuses on people at higher kidney risk, especially those with diabetes or high blood pressure.
Hear when a new Contrast-Induced Acute Kidney Injury in ST-Segment Elevation Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.